Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Evolving business
<< Previous
 Bullboard Posts
User Avatar Image
(3)
•••
Comment by QContinuum10on Jan 10, 2025 12:25pm
35 Views
Post# 36398239

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
Clongobongo wrote: It's not that hard, if you look at the Teuto approval, you can see some documents titled with 20 Mg/ml and 50 mg/ml.



Indeed, however confusingly, in that approval, there are no similar documents for the approved 100/250 concentrations that make up, at least to these eyes, the actual submission.

If Teuto ganged the products under one submission, it isn't clear where in the process those other two products are since, if you click on the project code and history, the final status is 'approved' with no other items outstanding.

Either way, it really isn't on us to try and sleuth this kind of stuff, it should be on leadership to overtly tell us what's going on and by when do they expect it.
<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities